List of redirects

Jump to: navigation, search

Showing below up to 50 results in range #1 to #50.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. 5-FU →‎ Fluorouracil (5-FU)
  2. 5-fluorouracil →‎ Fluorouracil (5-FU)
  3. 5FU →‎ Fluorouracil (5-FU)
  4. ABT-199 (GDC-0199) →‎ Venetoclax (Venclexta)
  5. AG-120 →‎ Ivosidenib (AG-120)
  6. AG-221 →‎ Enasidenib (Idhifa)
  7. AMG 386 →‎ Trebananib (AMG 386)
  8. ARN-509 →‎ Apalutamide (ARN-509)
  9. ATLL →‎ Adult T-cell leukemia-lymphoma
  10. Abemaciclib (LY2835219) →‎ Abemaciclib (Verzenio)
  11. Abiraterone →‎ Abiraterone (Zytiga)
  12. Abraxane →‎ Paclitaxel, nanoparticle albumin-bound (Abraxane)
  13. Acalabrutinib (ACP-196) →‎ Acalabrutinib (Calquence)
  14. Aclarubicin (Aclacinomycin) →‎ Aclarubicin (Aclacinon)
  15. Actinium-225 (225Ac)-Lintuzumab (Actimab-A) →‎ Actinium Ac 225 lintuzumab (Actimab-A)
  16. Acute lymphocytic leukemia →‎ B-cell acute lymphoblastic leukemia
  17. Acute myeloblastic leukemia →‎ Acute myeloid leukemia
  18. Acute myelogenous leukemia →‎ Acute myeloid leukemia
  19. Acute myeloid leukaemia →‎ Acute myeloid leukemia
  20. Acute myeloid leukaemia, FLT3-positive →‎ Acute myeloid leukemia, FLT3-positive
  21. Acute myeloid leukaemia, IDH-mutated →‎ Acute myeloid leukemia, IDH-mutated
  22. Acute promyelocytic leukaemia →‎ Acute promyelocytic leukemia
  23. Adult T-cell leukaemia-lymphoma →‎ Adult T-cell leukemia-lymphoma
  24. Afatinib (BIBW 2992) →‎ Afatinib (Gilotrif)
  25. Afatinib (Gliotrif) →‎ Afatinib (Gilotrif)
  26. Aflibercept (Zaltrap) →‎ Ziv-aflibercept (Zaltrap)
  27. Afuresertib →‎ Afuresertib (GSK2110183)
  28. Allogeneic HSCT conditioning regimens →‎ Allogeneic HSCT
  29. Aml →‎ Acute myeloid leukemia
  30. Anal carcinoma →‎ Anal cancer
  31. Andexanet alfa (PRT4445) →‎ Factor Xa, recombinant, inactivated-zhzo (Andexxa)
  32. Antidepressants →‎ Antidepressants and other psychiatric medications in cancer care
  33. Antithrombin III (Thrombate III) →‎ Antithrombin III (human and recombinant)
  34. Apalutamide (ARN-509) →‎ Apalutamide (Erleada)
  35. Apatinib (YN968D1) →‎ Apatinib (Aitan)
  36. Apl →‎ Acute promyelocytic leukemia
  37. Apml →‎ Acute promyelocytic leukemia
  38. Ara-C →‎ Cytarabine (Cytosar)
  39. Argatroban →‎ Argatroban (Acova)
  40. Atezolizumab (MPDL3280A) →‎ Atezolizumab (Tecentriq)
  41. Autoimmune thrombocytopenic purpura (ITP) →‎ Immune thrombocytopenia (ITP)
  42. Autologous HSCT conditioning regimens →‎ Autologous HSCT
  43. Avatrombopag (E5501) →‎ Avatrombopag (Doptelet)
  44. Axicabtagene ciloleucel (KTE-C19) →‎ Axicabtagene ciloleucel (Yescarta)
  45. B-cell acute lymphoblastic leukaemia →‎ B-cell acute lymphoblastic leukemia
  46. B-cell acute lymphoblastic leukaemia, Ph-positive →‎ B-cell acute lymphoblastic leukemia, Ph-positive
  47. BHQ880 (Anti-DKK1 Antibody) →‎ BHQ880
  48. BIDMC clinical trials →‎ Clinical trials
  49. Bacillus Calmette-Guerin (BCG, TheraCys) →‎ Bacillus Calmette-Guerin (BCG)
  50. Basal cell and squamous cell skin cancer →‎ Cutaneous basal cell carcinoma

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)